YPrime Launches eCOA Gen 5

Article

YPrime, LLC has announced the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform. YPrime’s newest platform features an improved user experience for patients, clinical investigators, sponsors, and CROs. YPrime’s platform aims to help patients remain engaged and compliant through straightforward design. They offer a customized solution with the necessary control and security that collects data from specification to submission.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.